MFA
SYNH

McClarren Financial Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

McClarren Financial Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3
Closed – – 485
2023
Q1 		$0 Hold
3
– – ﹤0.01% 480
2022
Q4 		$0 Buy
+3
New +$119 ﹤0.01% 490

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

McClarren Financial Advisors's SYNH Position: Q2 2023 in Review

McClarren Financial Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 3 shares.

McClarren Financial Advisors first reported a position in SYNH in Q4 2022 and held it in 2 quarters. The position peaked at $0 in Q1 2023. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • McClarren Financial Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • McClarren Financial Advisors sold 3 Syneos Health, Inc. Class A Common Stock shares in Q2 2023.
  • McClarren Financial Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2022 and held it in 2 quarters.
  • McClarren Financial Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $0 in Q1 2023.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on McClarren Financial Advisors's 13F filing for Q2 2023, filed 7 Aug 2023.